Skip to main content

Veraxa Biotech AG - Post de-SPAC

VRXA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002079109

In the last 90 days, Veraxa Biotech AG - Post de-SPAC insiders filed 2 open-market purchases and 0 sales; 8 institutions reported holding it in 13F filings for Q2 2026, worth $599.6K in total; no superinvestor holds it.

Other share classesVRXAW

13F holders, Q2 2026

Institutional positions in Veraxa Biotech AG - Post de-SPAC as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
8
+8 vs. Q1 2026
Shares held
483.9K
+483.9K vs. Q1 2026
Total value
$599.6K
+$599.6K vs. Q1 2026
New holders
8
0 more added
Sold out
0
0 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRXA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 8 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 8 institutions
Value heldQ2 2026: $599.6K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $599.6K
Institutions holding VRXA and their total value by quarter
QuarterHoldersValue
Q2 20268$599.6K
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Veraxa Biotech AG - Post de-SPAC; share changes are against Q1 2026.

Institutions holding VRXA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Group AG157,237$295.6K0.00%+157,237New
Geode Capital Management, LLC119,767$225.2K0.00%+119,767New
HRT Financial LP18,874$35.0K0.00%+18,874New
Susquehanna International Group, LLP10,833$20.4K0.00%+10,833New
Picton Mahoney Asset Management175,000$19.3K0.00%+175,000New
Wolverine Asset Management LLC1,748$3.29K0.00%+1,748New
JPMorgan Chase & Co396$8590.00%+396New
Caitong International Asset Management Co., Ltd6$110.00%+6New